肾移植耐受中记忆调节性T细胞驱动ATP降解增强
该研究分析肾移植耐受患者、健康志愿者及稳定移植物功能患者记忆调节性T细胞降解细胞外ATP的能力,并探讨免疫抑制药物对此过程的影响。发现耐受患者记忆Treg具有正常降解ATP/ADP的能力,而稳定功能患者记忆Treg无此能力。免疫抑制药物可能降低稳定患者记忆Treg比例,但不影响CD39依赖的ATP降解。
要点
- 耐受患者记忆Treg保持正常降解细胞外ATP/ADP的能力。
- 稳定移植物功能患者记忆Treg缺乏降解细胞外ATP/ADP的能力。
- 免疫抑制药物不影响CD39依赖的ATP降解能力。
核心结论
- 肾移植耐受患者记忆Treg通过维持CD39功能降解细胞外ATP/ADP,可能参与移植耐受的主动调节机制。
研究设计与样本
- 研究分析耐受患者、健康志愿者和稳定移植物功能患者的记忆Treg降解细胞外ATP的能力,并体外探讨免疫抑制药物的作用。
主要发现
- 耐受患者记忆Treg比例保守,建立促耐受平衡,且具有正常降解细胞外ATP/ADP的能力。
- 稳定移植物功能患者记忆Treg不具有降解细胞外ATP/ADP的能力。
- 体外免疫抑制药物可能促进稳定患者记忆Treg比例降低,但对CD39依赖的ATP降解无影响。
临床怎么用
- 监测记忆Treg的CD39依赖ATP降解能力可能有助于评估肾移植耐受状态。
- 免疫抑制药物停用后,耐受患者内在主动调节机制可能长期维持CD39 Treg功能。
局限性
- 原文未明确报告样本量、具体数值及统计显著性。
- 机制结论主要基于体外实验,需进一步体内验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Regulatory T cells were recently proposed as the central actor in operational tolerance after renal transplantation. Tolerant patients harbor increased FoxP3hi memory Treg frequency and increased demethylation in the Foxp3 Treg-specific demethylated region when compared to stable kidney recipients and exhibit greater memory Treg suppressive capacities and higher expression of the ectonucleotidase CD39. However, in this particular and unique situation the mechanisms of action of Tregs were not identified. Thus, we analyzed the ability of memory Tregs to degrade extracellular ATP in tolerant patients, healthy volunteers, and patients with stable graft function under immunosuppression and determined the role of immunosuppressive drugs on this process. The conserved proportion of memory Tregs leads to the establishment of a pro-tolerogenic balance in operationally tolerant patients. Memory Tregs in tolerant patients display normal capacity to degrade extracellular ATP/ADP. In contrast, memory Tregs from patients with stable graft function do not have this ability. Finally, in vitro, immunosuppressive drugs may favor the lower proportion of memory Tregs in stable patients, but they have no effect on CD39-dependent ATP degradation and do not explain memory Treg lack of extracellular ATP/ADP degradation ability. Thus, intrinsic active regulatory mechanisms may act long after immunosuppressive drug arrest in operationally tolerant patients and may contribute to kidney allograft tolerance via the maintenance of CD39 Treg function.
引用
- Durand M, Dubois F, Dejou C, et al. Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance. Kidney Int. 2018. PMID: 29455908. doi:10.1016/j.kint.2017.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。